サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1379087

ウェアラブル注射器市場：世界の産業動向、シェア、市場規模、成長、機会、2023～2028年予測

Wearable Injectors Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028
出版日: | 発行: IMARC | ページ情報: 英文 138 Pages | 納期: 2～3営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=155.76円
ウェアラブル注射器市場：世界の産業動向、シェア、市場規模、成長、機会、2023～2028年予測
出版日: 2023年11月02日
発行: IMARC
ページ情報: 英文 138 Pages
納期: 2～3営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

概要

ウェアラブル注射器の世界市場規模は2022年に66億米ドルに達しました。今後、IMARC Groupは、市場は2028年までに156億米ドルに達し、2022～2028年の成長率（CAGR）は15.4%になると予測しています。

ウェアラブル注射器（パッチポンプ）は、薬の一段階投与や長時間投与に使用されるコンパクトなドラッグデリバリー機器です。一時的に皮膚に貼り付けることで、体内の皮下組織を通して粘性の高い薬剤をより速く安全に大量に投与することができます。一般的にオンボディ型とオフボディ型があり、薬剤を貯蔵するリザーバー、組織に薬剤をデリバリーするカニューレ、適切な量の薬剤をデリバリーする駆動システムで構成されています。従来使用されてきたバイアルや注射器と比較して、ウェアラブル注射器は使い捨てで使い勝手がよく、不快感や痛みを最小限に抑えることができます。その結果、がん、糖尿病、関節リウマチ、心血管疾患の治療に広く使用されています。

ウェアラブル注射器市場の動向：

腫瘍性疾患、神経疾患、自己免疫疾患などの慢性疾患の有病率の増加は、市場成長を促進する主な要因の一つです。さらに、このような病気にかかりやすい老年人口が増加していることや、患者の間で低侵襲（MI）治療の選択肢に対する需要が高まっていることも、市場の成長を後押ししています。また、不正確な投与や針刺し損傷などのリスクを最小限に抑えながら効果的に病気を管理するため、自宅で自己投与可能な注射器への嗜好も高まっています。さらに、パッシブ警告システム、ワイヤレス接続、ブルートゥース技術の注射器への統合など、様々な製品革新が他の成長促進要因として作用しています。これらの技術は、スマートフォンのアプリケーションを通じて患者の便利なモニタリングを容易にし、投与量のタイムリーなリマインダーを提供します。その他の要因としては、広範な研究開発活動、特に新興経済諸国におけるヘルスケアインフラの大幅な改善などが挙げられ、市場の成長を後押しすると予想されます。

本レポートで扱う主な質問

  • ウェアラブル注射器の世界市場はこれまでどのように推移してきたか？
  • COVID-19がウェアラブル注射器の世界市場に与えた影響は？
  • 主要な地域市場は？
  • タイプ別の市場内訳は？
  • 技術別の市場内訳は？
  • 用途別の市場内訳は？
  • 最終用途別の市場内訳は？
  • 業界のバリューチェーンにおける様々な段階とは？
  • 業界の主要な促進要因と課題は何か？
  • ウェアラブル注射器の世界市場構造と主要プレイヤーは？
  • 業界の競合の程度は？

目次

第1章 序文

第2章 調査範囲と調査手法

  • 調査目的
  • 利害関係者
  • データソース
    • 一次情報
    • 二次情報
  • 市場推定
    • ボトムアップアプローチ
    • トップダウンアプローチ
  • 調査手法

第3章 エグゼクティブサマリー

第4章 イントロダクション

  • 概要
  • 主要産業動向

第5章 ウェアラブル注射器の世界市場

  • 市場概要
  • 市場実績
  • COVID-19の影響
  • 市場予測

第6章 市場内訳：タイプ別

  • オンボディ
    • 市場動向
    • 市場予測
  • オフボディ
    • 市場動向
    • 市場予測

第7章 市場内訳：技術別

  • スプリングベース
    • 市場動向
    • 市場予測
  • モーター駆動
    • 市場動向
    • 市場予測
  • ロータリーポンプ
    • 市場動向
    • 市場予測
  • 拡張バッテリー
    • 市場動向
    • 市場予測
  • その他
    • 市場動向
    • 市場予測

第8章 市場内訳：用途別

  • オンコロジー
    • 市場動向
    • 市場予測
  • 感染症
    • 市場動向
    • 市場予測
  • 循環器疾患
    • 市場動向
    • 市場予測
  • 自己免疫疾患
    • 市場動向
    • 市場予測
  • その他
    • 市場動向
    • 市場予測

第9章 市場内訳：最終用途別

  • 病院・クリニック
    • 市場動向
    • 市場予測
  • 在宅医療
    • 市場動向
    • 市場予測
  • その他
    • 市場動向
    • 市場予測

第10章 市場内訳：地域別

  • 北米
    • 米国
      • 市場動向
      • 市場予測
    • カナダ
      • 市場動向
      • 市場予測
  • アジア太平洋
    • 中国
      • 市場動向
      • 市場予測
    • 日本
      • 市場動向
      • 市場予測
    • インド
      • 市場動向
      • 市場予測
    • 韓国
      • 市場動向
      • 市場予測
    • オーストラリア
      • 市場動向
      • 市場予測
    • インドネシア
      • 市場動向
      • 市場予測
    • その他
      • 市場動向
      • 市場予測
  • 欧州
    • ドイツ
      • 市場動向
      • 市場予測
    • フランス
      • 市場動向
      • 市場予測
    • 英国
      • 市場動向
      • 市場予測
    • イタリア
      • 市場動向
      • 市場予測
    • スペイン
      • 市場動向
      • 市場予測
    • ロシア
      • 市場動向
      • 市場予測
    • その他
      • 市場動向
      • 市場予測
  • ラテンアメリカ
    • ブラジル
      • 市場動向
      • 市場予測
    • メキシコ
      • 市場動向
      • 市場予測
    • その他
      • 市場動向
      • 市場予測
  • 中東・アフリカ地域
    • 市場動向
    • 市場内訳：国別
    • 市場予測

第11章 SWOT分析

  • 概要
  • 強み
  • 弱み
  • 機会
  • 脅威

第12章 バリューチェーン分析

第13章 ポーターのファイブフォース分析

  • 概要
  • 買い手の交渉力
  • 供給企業の交渉力
  • 競合の程度
  • 新規参入業者の脅威
  • 代替品の脅威

第14章 価格分析

第15章 競合情勢

  • 市場構造
  • 主要企業
  • 主要企業のプロファイル
    • Becton Dickinson and Company
    • CeQur SA
    • Debiotech SA
    • Dexcom Inc.
    • Enable Injections Inc.
    • Gerresheimer AG
    • Insulet Corporation
    • Tandem Diabetes Care Inc.
    • West Pharmaceutical Services Inc.
    • Ypsomed AG
図表

List of Figures

  • Figure 1: Global: Wearable Injectors Market: Major Drivers and Challenges
  • Figure 2: Global: Wearable Injectors Market: Sales Value (in Billion US$), 2017-2022
  • Figure 3: Global: Wearable Injectors Market Forecast: Sales Value (in Billion US$), 2023-2028
  • Figure 4: Global: Wearable Injectors Market: Breakup by Type (in %), 2022
  • Figure 5: Global: Wearable Injectors Market: Breakup by Technology (in %), 2022
  • Figure 6: Global: Wearable Injectors Market: Breakup by Application (in %), 2022
  • Figure 7: Global: Wearable Injectors Market: Breakup by End Use (in %), 2022
  • Figure 8: Global: Wearable Injectors Market: Breakup by Region (in %), 2022
  • Figure 9: Global: Wearable Injectors (On-body) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 10: Global: Wearable Injectors (On-body) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 11: Global: Wearable Injectors (Off-body) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 12: Global: Wearable Injectors (Off-body) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 13: Global: Wearable Injectors (Spring-based) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 14: Global: Wearable Injectors (Spring-based) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 15: Global: Wearable Injectors (Motor-driven) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 16: Global: Wearable Injectors (Motor-driven) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 17: Global: Wearable Injectors (Rotary Pump) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 18: Global: Wearable Injectors (Rotary Pump) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 19: Global: Wearable Injectors (Expanding Battery) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 20: Global: Wearable Injectors (Expanding Battery) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 21: Global: Wearable Injectors (Other Technologies) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 22: Global: Wearable Injectors (Other Technologies) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 23: Global: Wearable Injectors (Oncology) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 24: Global: Wearable Injectors (Oncology) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 25: Global: Wearable Injectors (Infectious Diseases) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 26: Global: Wearable Injectors (Infectious Diseases) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 27: Global: Wearable Injectors (Cardiovascular Diseases) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 28: Global: Wearable Injectors (Cardiovascular Diseases) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 29: Global: Wearable Injectors (Autoimmune Diseases) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 30: Global: Wearable Injectors (Autoimmune Diseases) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 31: Global: Wearable Injectors (Other Applications) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 32: Global: Wearable Injectors (Other Applications) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 33: Global: Wearable Injectors (Hospitals and Clinics) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 34: Global: Wearable Injectors (Hospitals and Clinics) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 35: Global: Wearable Injectors (Home Care) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 36: Global: Wearable Injectors (Home Care) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 37: Global: Wearable Injectors (Other End Uses) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 38: Global: Wearable Injectors (Other End Uses) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 39: North America: Wearable Injectors Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 40: North America: Wearable Injectors Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 41: United States: Wearable Injectors Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 42: United States: Wearable Injectors Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 43: Canada: Wearable Injectors Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 44: Canada: Wearable Injectors Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 45: Asia-Pacific: Wearable Injectors Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 46: Asia-Pacific: Wearable Injectors Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 47: China: Wearable Injectors Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 48: China: Wearable Injectors Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 49: Japan: Wearable Injectors Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 50: Japan: Wearable Injectors Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 51: India: Wearable Injectors Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 52: India: Wearable Injectors Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 53: South Korea: Wearable Injectors Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 54: South Korea: Wearable Injectors Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 55: Australia: Wearable Injectors Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 56: Australia: Wearable Injectors Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 57: Indonesia: Wearable Injectors Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 58: Indonesia: Wearable Injectors Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 59: Others: Wearable Injectors Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 60: Others: Wearable Injectors Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 61: Europe: Wearable Injectors Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 62: Europe: Wearable Injectors Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 63: Germany: Wearable Injectors Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 64: Germany: Wearable Injectors Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 65: France: Wearable Injectors Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 66: France: Wearable Injectors Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 67: United Kingdom: Wearable Injectors Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 68: United Kingdom: Wearable Injectors Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 69: Italy: Wearable Injectors Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 70: Italy: Wearable Injectors Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 71: Spain: Wearable Injectors Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 72: Spain: Wearable Injectors Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 73: Russia: Wearable Injectors Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 74: Russia: Wearable Injectors Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 75: Others: Wearable Injectors Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 76: Others: Wearable Injectors Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 77: Latin America: Wearable Injectors Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 78: Latin America: Wearable Injectors Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 79: Brazil: Wearable Injectors Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 80: Brazil: Wearable Injectors Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 81: Mexico: Wearable Injectors Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 82: Mexico: Wearable Injectors Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 83: Others: Wearable Injectors Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 84: Others: Wearable Injectors Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 85: Middle East and Africa: Wearable Injectors Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 86: Middle East and Africa: Wearable Injectors Market: Breakup by Country (in %), 2022
  • Figure 87: Middle East and Africa: Wearable Injectors Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 88: Global: Wearable Injectors Industry: SWOT Analysis
  • Figure 89: Global: Wearable Injectors Industry: Value Chain Analysis
  • Figure 90: Global: Wearable Injectors Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Wearable Injectors Market: Key Industry Highlights, 2022 and 2028
  • Table 2: Global: Wearable Injectors Market Forecast: Breakup by Type (in Million US$), 2023-2028
  • Table 3: Global: Wearable Injectors Market Forecast: Breakup by Technology (in Million US$), 2023-2028
  • Table 4: Global: Wearable Injectors Market Forecast: Breakup by Application (in Million US$), 2023-2028
  • Table 5: Global: Wearable Injectors Market Forecast: Breakup by End Use (in Million US$), 2023-2028
  • Table 6: Global: Wearable Injectors Market Forecast: Breakup by Region (in Million US$), 2023-2028
  • Table 7: Global: Wearable Injectors Market: Competitive Structure
  • Table 8: Global: Wearable Injectors Market: Key Players
目次
Product Code: SR112023A3992

Abstract

The global wearable injectors market size reached US$ 6.6 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 15.6 Billion by 2028, exhibiting a growth rate (CAGR) of 15.4% during 2022-2028.

Wearable injectors, or patch pumps, are compact drug delivery devices used for single-step administration of medicines for longer durations. They are temporarily pasted on the skin to deliver viscous drugs in large volumes faster and safely through the subcutaneous tissues in the body. They are commonly available in on-body and off-body injector variants and the device consists of a reservoir to store medicine, a cannula for substance delivery to tissues and a drive system to deliver the appropriate drug volume. In comparison to the traditionally used vials and syringes, wearable injectors are disposable, user-friendly, cause minimal discomfort and pain. As a result, they are widely used in the treatment of cancer, diabetes, rheumatoid arthritis and cardiovascular diseases.

Wearable Injectors Market Trends:

The increasing prevalence of chronic medical ailments, such as oncological, neurological and autoimmune disorders, is of the key factors driving the market growth. Moreover, the rising geriatric population, which is more susceptible to such ailments, and the increasing demand for minimally invasive (MI) treatment alternatives among the patients are providing a thrust to the growth of the market. There is also a growing preference for at-home and self-administrable injectors to effectively manage the ailments with minimal risks of inaccurate dosage and needle stick injuries. Additionally, various product innovations, such as integration of passive warning systems, wireless connectivity and Bluetooth technologies with the injectors, are acting as other growth-inducing factors. These technologies facilitate convenient monitoring of the patient through a smartphone application and provide timely reminders for dosages. Other factors, including extensive research and development activities, along with significant improvements in the healthcare infrastructure, especially in the developing economies, are anticipating to the drive the market toward growth.

Key Market Segmentation:

IMARC Group provides an analysis of the key trends in each sub-segment of the global wearable injectors market report, along with forecasts at the global, regional and country level from 2023-2028. Our report has categorized the market based on type, technology, application and end use.

Breakup by Type:

On-body

Off-body

Breakup by Technology:

Spring-based

Motor-driven

Rotary Pump

Expanding Battery

Others

Breakup by Application:

Oncology

Infectious Diseases

Cardiovascular Diseases

Autoimmune Diseases

Others

Breakup by End Use:

Hospitals and Clinics

Home Care

Others

Breakup by Region:

North America

United States

Canada

Asia-Pacific

China

Japan

India

South Korea

Australia

Indonesia

Others

Europe

Germany

France

United Kingdom

Italy

Spain

Russia

Others

Latin America

Brazil

Mexico

Others

Middle East and Africa

Competitive Landscape:

The competitive landscape of the industry has also been examined along with the profiles of the key players being Becton Dickinson and Company, CeQur SA, Debiotech SA, Dexcom Inc., Enable Injections Inc., Gerresheimer AG, Insulet Corporation, Tandem Diabetes Care Inc., West Pharmaceutical Services Inc. and Ypsomed AG.

Key Questions Answered in This Report:

  • How has the global wearable injectors market performed so far and how will it perform in the coming years?
  • What has been the impact of COVID-19 on the global wearable injectors market?
  • What are the key regional markets?
  • What is the breakup of the market based on the type?
  • What is the breakup of the market based on the technology?
  • What is the breakup of the market based on the application?
  • What is the breakup of the market based on the end use?
  • What are the various stages in the value chain of the industry?
  • What are the key driving factors and challenges in the industry?
  • What is the structure of the global wearable injectors market and who are the key players?
  • What is the degree of competition in the industry?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Wearable Injectors Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Type

  • 6.1 On-body
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2 Off-body
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast

7 Market Breakup by Technology

  • 7.1 Spring-based
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Motor-driven
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast
  • 7.3 Rotary Pump
    • 7.3.1 Market Trends
    • 7.3.2 Market Forecast
  • 7.4 Expanding Battery
    • 7.4.1 Market Trends
    • 7.4.2 Market Forecast
  • 7.5 Others
    • 7.5.1 Market Trends
    • 7.5.2 Market Forecast

8 Market Breakup by Application

  • 8.1 Oncology
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Infectious Diseases
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast
  • 8.3 Cardiovascular Diseases
    • 8.3.1 Market Trends
    • 8.3.2 Market Forecast
  • 8.4 Autoimmune Diseases
    • 8.4.1 Market Trends
    • 8.4.2 Market Forecast
  • 8.5 Others
    • 8.5.1 Market Trends
    • 8.5.2 Market Forecast

9 Market Breakup by End Use

  • 9.1 Hospitals and Clinics
    • 9.1.1 Market Trends
    • 9.1.2 Market Forecast
  • 9.2 Home Care
    • 9.2.1 Market Trends
    • 9.2.2 Market Forecast
  • 9.3 Others
    • 9.3.1 Market Trends
    • 9.3.2 Market Forecast

10 Market Breakup by Region

  • 10.1 North America
    • 10.1.1 United States
      • 10.1.1.1 Market Trends
      • 10.1.1.2 Market Forecast
    • 10.1.2 Canada
      • 10.1.2.1 Market Trends
      • 10.1.2.2 Market Forecast
  • 10.2 Asia-Pacific
    • 10.2.1 China
      • 10.2.1.1 Market Trends
      • 10.2.1.2 Market Forecast
    • 10.2.2 Japan
      • 10.2.2.1 Market Trends
      • 10.2.2.2 Market Forecast
    • 10.2.3 India
      • 10.2.3.1 Market Trends
      • 10.2.3.2 Market Forecast
    • 10.2.4 South Korea
      • 10.2.4.1 Market Trends
      • 10.2.4.2 Market Forecast
    • 10.2.5 Australia
      • 10.2.5.1 Market Trends
      • 10.2.5.2 Market Forecast
    • 10.2.6 Indonesia
      • 10.2.6.1 Market Trends
      • 10.2.6.2 Market Forecast
    • 10.2.7 Others
      • 10.2.7.1 Market Trends
      • 10.2.7.2 Market Forecast
  • 10.3 Europe
    • 10.3.1 Germany
      • 10.3.1.1 Market Trends
      • 10.3.1.2 Market Forecast
    • 10.3.2 France
      • 10.3.2.1 Market Trends
      • 10.3.2.2 Market Forecast
    • 10.3.3 United Kingdom
      • 10.3.3.1 Market Trends
      • 10.3.3.2 Market Forecast
    • 10.3.4 Italy
      • 10.3.4.1 Market Trends
      • 10.3.4.2 Market Forecast
    • 10.3.5 Spain
      • 10.3.5.1 Market Trends
      • 10.3.5.2 Market Forecast
    • 10.3.6 Russia
      • 10.3.6.1 Market Trends
      • 10.3.6.2 Market Forecast
    • 10.3.7 Others
      • 10.3.7.1 Market Trends
      • 10.3.7.2 Market Forecast
  • 10.4 Latin America
    • 10.4.1 Brazil
      • 10.4.1.1 Market Trends
      • 10.4.1.2 Market Forecast
    • 10.4.2 Mexico
      • 10.4.2.1 Market Trends
      • 10.4.2.2 Market Forecast
    • 10.4.3 Others
      • 10.4.3.1 Market Trends
      • 10.4.3.2 Market Forecast
  • 10.5 Middle East and Africa
    • 10.5.1 Market Trends
    • 10.5.2 Market Breakup by Country
    • 10.5.3 Market Forecast

11 SWOT Analysis

  • 11.1 Overview
  • 11.2 Strengths
  • 11.3 Weaknesses
  • 11.4 Opportunities
  • 11.5 Threats

12 Value Chain Analysis

13 Porters Five Forces Analysis

  • 13.1 Overview
  • 13.2 Bargaining Power of Buyers
  • 13.3 Bargaining Power of Suppliers
  • 13.4 Degree of Competition
  • 13.5 Threat of New Entrants
  • 13.6 Threat of Substitutes

14 Price Analysis

15 Competitive Landscape

  • 15.1 Market Structure
  • 15.2 Key Players
  • 15.3 Profiles of Key Players
    • 15.3.1 Becton Dickinson and Company
      • 15.3.1.1 Company Overview
      • 15.3.1.2 Product Portfolio
      • 15.3.1.3 Financials
      • 15.3.1.4 SWOT Analysis
    • 15.3.2 CeQur SA
      • 15.3.2.1 Company Overview
      • 15.3.2.2 Product Portfolio
    • 15.3.3 Debiotech SA
      • 15.3.3.1 Company Overview
      • 15.3.3.2 Product Portfolio
    • 15.3.4 Dexcom Inc.
      • 15.3.4.1 Company Overview
      • 15.3.4.2 Product Portfolio
      • 15.3.4.3 Financials
      • 15.3.4.4 SWOT Analysis
    • 15.3.5 Enable Injections Inc.
      • 15.3.5.1 Company Overview
      • 15.3.5.2 Product Portfolio
    • 15.3.6 Gerresheimer AG
      • 15.3.6.1 Company Overview
      • 15.3.6.2 Product Portfolio
      • 15.3.6.3 Financials
    • 15.3.7 Insulet Corporation
      • 15.3.7.1 Company Overview
      • 15.3.7.2 Product Portfolio
      • 15.3.7.3 Financials
      • 15.3.7.4 SWOT Analysis
    • 15.3.8 Tandem Diabetes Care Inc.
      • 15.3.8.1 Company Overview
      • 15.3.8.2 Product Portfolio
      • 15.3.8.3 Financials
    • 15.3.9 West Pharmaceutical Services Inc.
      • 15.3.9.1 Company Overview
      • 15.3.9.2 Product Portfolio
      • 15.3.9.3 Financials
    • 15.3.10 Ypsomed AG
      • 15.3.10.1 Company Overview
      • 15.3.10.2 Product Portfolio
      • 15.3.10.3 Financials
      • 15.3.10.4 SWOT Analysis